Copyright
©2010 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastrointest Pharmacol Ther. Oct 6, 2010; 1(5): 112-118
Published online Oct 6, 2010. doi: 10.4292/wjgpt.v1.i5.112
Published online Oct 6, 2010. doi: 10.4292/wjgpt.v1.i5.112
An open-label, randomized, cross-over bioequivalence study of lafutidine 10 mg under fasting condition
Bhupesh Dewan, Director Medical Services, Zuventus Healthcare Ltd., Mumbai 400072, India
Raghuram Chimata, Clinical Research Associate, Zuventus Healthcare Ltd., Mumbai 400072, India
Author contributions: Dewan B was involved in the conceptualization of the study, designing of the protocol, initiation, supervision, auditing of the sites, interpretation of the data and statistical outcomes and revision of the manuscript drafts; Chimata R was involved in monitoring of the study, statistical analysis and interpretation of the data and the compilation of the manuscript draft; all the authors read and approved the final version of the manuscript.
Correspondence to: Dr. Bhupesh Dewan, MBBS, MD, Director Medical Services, Zuventus Healthcare Ltd., 5119 ‘D’ Wing, Oberoi Garden Estate, Chandivilli, Mumbai 400 072, India. bhupesh.dewan@zuventus.com
Telephone: +91-22-28472823 Fax: +91-22-28472828
Received: April 23, 2010
Revised: September 21, 2010
Accepted: September 28, 2010
Published online: October 6, 2010
Revised: September 21, 2010
Accepted: September 28, 2010
Published online: October 6, 2010
Core Tip